United States · FDA National Drug Code directory

GABAPENTIN

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
71335-0993_424a9673-5bd1-4a75-8b1f-09a69b5043c0
Product NDC
71335-0993
Form
CAPSULE
Composition / generic term
GABAPENTIN
Labeler
Bryant Ranch Prepack
Marketing category
ANDA
Marketing start / end (source format)
20151230
Source listing expiry
20261231

Source-listed ingredients

  • GABAPENTIN — 300 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 90 CAPSULE in 1 BOTTLE (71335-0993-1) · 71335-0993-1
  • 28 CAPSULE in 1 BOTTLE (71335-0993-2) · 71335-0993-2
  • 58 CAPSULE in 1 BOTTLE (71335-0993-3) · 71335-0993-3
  • 30 CAPSULE in 1 BOTTLE (71335-0993-4) · 71335-0993-4
  • 60 CAPSULE in 1 BOTTLE (71335-0993-5) · 71335-0993-5
  • 120 CAPSULE in 1 BOTTLE (71335-0993-6) · 71335-0993-6
  • 180 CAPSULE in 1 BOTTLE (71335-0993-7) · 71335-0993-7
  • 40 CAPSULE in 1 BOTTLE (71335-0993-8) · 71335-0993-8

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →